ReviewCureus2026
Antimicrobial Resistance in Africa: Public Health Challenges and Lessons From Morocco.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antimicrobial resistance (AMR) is recognized as one of the leading global public health threats, with a disproportionate impact on low- and middle-income countries, particularly in Africa, where high infectious disease burden, inappropriate antibiotic use, limited diagnostic capacity, and heterogeneous surveillance systems contribute to the emergence and spread of resistant pathogens. This narrative review synthesizes current evidence on AMR in Africa while highlighting Morocco as a relevant case study to inform public health priorities. A comprehensive literature search was conducted using PubMed/MEDLINE, Scopus, and Google Scholar, complemented by grey literature and World Health Organization (WHO) reports. Evidence published between 2014 and 2025 addressing AMR, antibiotic use, surveillance, stewardship, and policy interventions in Africa was narratively synthesized. Available evidence indicates that in 2019, approximately 4.95 million deaths were associated with bacterial AMR globally, including 1.27 million deaths directly attributable to AMR, with the highest mortality rates reported in western Sub-Saharan Africa. Across African settings, AMR is driven by nonprescription antibiotic access, self-medication, empirical broad-spectrum prescribing, weak infection prevention and control measures, and insufficient microbiological diagnostics, while surveillance remains fragmented because of uneven implementation of the WHO-Global Antimicrobial Resistance and Use Surveillance System (GLASS) recommendations. Morocco reflects many of these continental challenges, including high resistance among WHO priority pathogens such as
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.